Managing women with gestational diabetes mellitus in the postnatal period
dc.contributor.author | Kim, Catherine | en_US |
dc.date.accessioned | 2010-06-01T19:07:58Z | |
dc.date.available | 2010-06-01T19:07:58Z | |
dc.date.issued | 2010-01 | en_US |
dc.identifier.citation | Kim, Catherine (2010). "Managing women with gestational diabetes mellitus in the postnatal period." Diabetes, Obesity and Metabolism 12(1): 20-25. <http://hdl.handle.net/2027.42/72319> | en_US |
dc.identifier.issn | 1462-8902 | en_US |
dc.identifier.issn | 1463-1326 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/72319 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=19788432&dopt=citation | en_US |
dc.format.extent | 490949 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | © 2010 Blackwell Publishing Ltd | en_US |
dc.subject.other | Gestational Diabetes | en_US |
dc.subject.other | Postpartum | en_US |
dc.subject.other | Women | en_US |
dc.title | Managing women with gestational diabetes mellitus in the postnatal period | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Departments of Medicine and Obstetrics & Gynecology, University of Michigan, Ann Arbor, MI, USA | en_US |
dc.identifier.pmid | 19788432 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/72319/1/j.1463-1326.2009.01147.x.pdf | |
dc.identifier.doi | 10.1111/j.1463-1326.2009.01147.x | en_US |
dc.identifier.source | Diabetes, Obesity and Metabolism | en_US |
dc.identifier.citedreference | O’Sullivan J, Mahan C. Criteria for the oral glucose tolerance test in pregnancy. Diabetes 1964; 13: 278 – 285. | en_US |
dc.identifier.citedreference | O’Sullivan J. Diabetes mellitus after GDM. Diabetes 1991; 29 (Suppl. 2): 131 – 135. | en_US |
dc.identifier.citedreference | Bellamy L, Casas J, Hingorani A, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009; 373: 1773 – 1779. | en_US |
dc.identifier.citedreference | Cheung N, Byth K. Population health significance of gestational diabetes. Diabetes Care 2003; 26: 2005 – 2009. | en_US |
dc.identifier.citedreference | Kim C, Berger D, Chamany S. Recurrence of gestational diabetes mellitus: a systematic review. Diabetes Care 2007; 30: 1314 – 1319. | en_US |
dc.identifier.citedreference | Buchanan T, Xiang A, Kjos S et al. Gestational diabetes: antepartum characteristics that predict postpartum glucose intolerance and type 2 diabetes in Latino women. Diabetes 1998; 47: 1302 – 1310. | en_US |
dc.identifier.citedreference | Buchanan T, Catalano P. The pathogenesis of GDM: implication for diabetes after pregnancy. Diabetes Rev 1995; 3: 584 – 601. | en_US |
dc.identifier.citedreference | 8 National Institute for Health and Clinical Excellence (NICE). Diabetes in Pregnancy: Management of Diabetes and its Complications from Preconception to the Postnatal Period. London: National Collaborating Centre for Women's and Children's Health; 2008. | en_US |
dc.identifier.citedreference | Metzger B, Buchanan T, Coustan D et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 2007; 30: S251 – S260. | en_US |
dc.identifier.citedreference | 10 ACOG Committee on Obstetric Practice. Postpartum screening for abnormal glucose tolerance in women who had gestational diabetes mellitus. Obstet Gynecol 2009; 113: 1419 – 1421. | en_US |
dc.identifier.citedreference | 11 World Health Organization. Definition, Diagnosis, and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1. Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization; 1999. | en_US |
dc.identifier.citedreference | 12 World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: A report of WHO/IDF consultation. Geneva: World Health Organization; 2006. | en_US |
dc.identifier.citedreference | 13 American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008; 31 (Suppl. 1): S55 – S60. | en_US |
dc.identifier.citedreference | 14 The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160 – 3167. | en_US |
dc.identifier.citedreference | Nathan D, Davidson M, DeFronzo R et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007; 30: 753 – 759. | en_US |
dc.identifier.citedreference | Harris M, Eastman R, Cowie C, Flegal K, Eberhardt M. Comparison of diabetes diagnostic categories in the U.S. population according to 1997 American Diabetes Association and 1980–1985 World Health Organization diagnostic criteria. Diabetes Care 1997; 20: 1859 – 1862. | en_US |
dc.identifier.citedreference | 17 DECODE Study Group. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? BMJ 1998; 317: 371 – 375. | en_US |
dc.identifier.citedreference | Mooy J, Grootenhuis P, de Vries H et al. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia 1996; 39: 298 – 305. | en_US |
dc.identifier.citedreference | Feskens E, Bowles C, Kromhout D. Intra- and interindividual variability of glucose tolerance in an elderly population. J Clin Epidemiol 1991; 44: 947 – 953. | en_US |
dc.identifier.citedreference | Holt R, Goddard J, Clark P, Coleman M. A postnatal fasting plasma glucose is useful in determining which women with gestational diabetes should undergo a postnatal oral glucose tolerance test. Diabet Med 2003; 20: 594 – 598. | en_US |
dc.identifier.citedreference | 21 The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183 – 1197. | en_US |
dc.identifier.citedreference | Ray J, O’Brien T, Chan W. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. Q J Med 2001; 94: 435 – 444. | en_US |
dc.identifier.citedreference | Harris M, Flegal K, Cowie C et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey. Diabetes Care 1998; 21: 518. | en_US |
dc.identifier.citedreference | Lawrence J, Contreras R, Sacks D. Trends in the Prevalence of Pre-Existing Diabetes and Gestational Diabetes Mellitus among a Racially/Ethnically Diverse Population of Pregnant Women, 1999–2005. Diabetes Care 2008; 31: 899 – 904. | en_US |
dc.identifier.citedreference | 25 The Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000; 342: 381 – 389. | en_US |
dc.identifier.citedreference | Kim C, Herman W, Vijan S. Efficacy and cost of postpartum screening strategies for diabetes among women with histories of gestational diabetes mellitus. Diabetes Care 2007; 30: 1102 – 1106. | en_US |
dc.identifier.citedreference | Knowler W, Hamman R, Edelstein S et al. Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program. Diabetes 2005; 54: 1150 – 1156. | en_US |
dc.identifier.citedreference | Tuomilehto J, Lindstrom J, Eriksson J et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343 – 1350. | en_US |
dc.identifier.citedreference | Ratner R. Women with a history of gestational diabetes in the Diabetes Prevention Program. Fourth International Workshop-Conference on Gestational Diabetes Mellitus, 11/13/2005 Chicago, IL; 2005. | en_US |
dc.identifier.citedreference | Ratner R. Prevention of type 2 diabetes in women with previous gestational diabetes. Diabetes Care 2007; 30 (Suppl. 2): S242 – S245. | en_US |
dc.identifier.citedreference | Kim C, Sinco B, Kieffer E. Racial and ethnic variation in access to healthcare, provision of healthcare services, and rating of health among women with a history of gestational diabetes mellitus. Diabetes Care 2007; 30: 1459 – 1465. | en_US |
dc.identifier.citedreference | O’Toole M, Sawicki M, Artal R. Structured diet and physical activity prevent postpartum weight retention. J Womens Health 2003; 12: 991 – 998. | en_US |
dc.identifier.citedreference | Leermarkers E, Anglin K, Wing R. Reducing postpartum weight retention through a correspondence intervention. Int J Obes 1998; 22: 1103 – 1109. | en_US |
dc.identifier.citedreference | Lovelady C, Garner K, Moreno K, Williams J. The effect of weight loss in overweight, lactating women on the growth of their infants. N Engl J Med 2000; 342: 449 – 453. | en_US |
dc.identifier.citedreference | Buchanan T, Xiang A, Peters R et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 2002; 51: 2796 – 2803. | en_US |
dc.identifier.citedreference | Xiang A, Peters R, Kjos S et al. Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes. Diabetes 2006; 55: 517 – 522. | en_US |
dc.identifier.citedreference | Mottola M. The role of exercise in the prevention and treatment of gestational diabetes mellitus. Curr Diab Rep 2008; 8: 299 – 304. | en_US |
dc.identifier.citedreference | Gunderson E, Lewis C, Tsai A et al. A 20-year prospective study of childbearing and incidence of diabetes in young women, controlling for glycemia before conception: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Diabetes 2007; 56: 2990 – 2996. | en_US |
dc.identifier.citedreference | Baptiste-Roberts K, Barone B, Gary T et al. Risk factors for type 2 diabetes among women with gestational diabetes: a systematic review. Am J Med 2009; 122: 207 – 214. | en_US |
dc.identifier.citedreference | Kennedy K, Visness C. Contraceptive efficacy of lactational amenorrhea. Lancet 1992; 339: 227 – 230. | en_US |
dc.identifier.citedreference | Olson C, Strawderman M, Hinton P, Pearson T. Gestational weight gain and postpartum behaviors associated with weight change from early pregnancy to 1 year postpartum. Int J Obes Relat Metab Disord 2003; 27: 117 – 127. | en_US |
dc.identifier.citedreference | McManus R, Cunningham I, Watson A, Harker L, Finegood D. Beta-cell function and visceral fat in lactating women with a history of gestational diabetes. Metabolism 2001; 50: 715 – 719. | en_US |
dc.identifier.citedreference | Kjos S, Peters R, Xiang A, Henry O, Montoro M, Buchanan T. Predicting future diabetes in Latino women with gestational diabetes. Diabetes 1995; 44: 586 – 591. | en_US |
dc.identifier.citedreference | Buchanan T, Xiang A, Kjos S, Trigo E, Lee W, Peters R. Antepartum predictors of the development of type 2 diabetes in Latino women 11–26 months after pregnancies complicated by gestational diabetes. Diabetes 1999; 48: 2430 – 2436. | en_US |
dc.identifier.citedreference | Stuebe A, Rich-Edwards J, Willett W, Manson J, Michels K. Duration of lactation and incidence of type 2 diabetes. JAMA 2005; 294: 2601 – 2610. | en_US |
dc.identifier.citedreference | Pettitt D, Knowler W. Long-term effects of the intrauterine environment, birth weight, and breast-feeding in Pima Indians. Diabetes Care 1998; 21 (Suppl. 2): B138 – B141. | en_US |
dc.identifier.citedreference | Mayer-Davis E, Dabelea D, Lamichhane A et al. Breast-feeding and type 2 diabetes in the youth of three ethnic groups: the SEARCH for diabetes in youth case-control study. Diabetes Care 2008; 31: 470 – 475. | en_US |
dc.identifier.citedreference | Young T, Martens P, Taback S et al. Type 2 diabetes mellitus in children: prenatal and early infancy risk factors among Native Canadians. Arch Pediatr Adolesc Med 2002; 156: 651 – 655. | en_US |
dc.identifier.citedreference | Labbok M, Hight-Laukaran V, Peterson A, Fletcher V, von Hertzen H, Van Look P. Multicenter study of the Lactational Amenorrhea Method (LAM): I. Efficacy, duration, and implications for clinical application. Contraception 1997; 55: 327 – 336. | en_US |
dc.identifier.citedreference | Skouby S, Kuhl C, Molsted-Pedersen L, Petersen K, Christensen M. Triphasic oral contraception: metabolic effects in normal women and those with previous gestational diabetes. Am J Obstet Gynecol 1985; 153: 495 – 500. | en_US |
dc.identifier.citedreference | Skouby S, Molsted-Pedersen L, Kuhl C. Low dosage oral contraception in women with previous gestational diabetes. Obstet Gynecol 1981; 59: 325 – 328. | en_US |
dc.identifier.citedreference | Lopez L, Grimes D, Schulz K. Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus. Cochrane Database Syst Rev 2007; CD006133. | en_US |
dc.identifier.citedreference | Kjos S, Peters R, Xiang A, Thomas D, Schaefer U, Buchanan T. Contraception and the risk of type 2 diabetes mellitus in Latina women with prior gestational diabetes mellitus. JAMA 1998; 280: 533 – 538. | en_US |
dc.identifier.citedreference | Petitti D. Clinical practice: combination estrogen-progestin oral contraceptives. N Engl J Med 2003; 349: 1443 – 1450. | en_US |
dc.identifier.citedreference | Madden T, Blumenthal P. Contraceptive vaginal ring. Clin Obstet Gynecol 2007; 50: 878 – 885. | en_US |
dc.identifier.citedreference | Hatcher R, Trussell J, Nelson A, Cates Jr W, Stewart F, Kowal D. Contraceptive Technology. New York City, NY: Ardent Media, Inc.; 2007. | en_US |
dc.identifier.citedreference | Goa K, Warner G, Easthope S. Transdermal ethinylestradiol/norelgestromin: a review of its use in hormonal contraception. Treat Endocrinol 2003; 2: 191 – 206. | en_US |
dc.identifier.citedreference | Chi I. The safety and efficacy issues of progestin-only oral contraceptives–an epidemiologic perspective. Contraception 1993; 47: 1 – 21. | en_US |
dc.identifier.citedreference | Kim C, Seidel K, Begier E, Kwok Y. Diabetes and depot medroxyprogesterone contraception in Navajo women. Arch Intern Med 2001; 161: 1766 – 1771. | en_US |
dc.identifier.citedreference | Xiang A, Kawakubo M, Kjos S, Buchanan T. Long-acting injectable progestin contraception and risk of type 2 diabetes in Latino women with prior gestational diabetes mellitus. Diabetes Care 2006; 29: 613 – 617. | en_US |
dc.identifier.citedreference | Kahn H, Curtis K, Marchbanks P. Effects of injectable or implantable progestin-only contraceptives on insulin-glucose metabolism and diabetes risk. Diabetes Care 2003; 26: 216 – 225. | en_US |
dc.identifier.citedreference | Thonneau P, Almont T. Contraceptive efficacy of intrauterine devices. Am J Obstet Gynecol 2008; 198: 248 – 253. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.